Pharmaceutical News and Articles
Comprehensive and up-to-date drug news for both consumers and healthcare professionals.
Including medical news, pharmaceutical industry news, new drug approvals, applications and clinical trial results.
Daily MedNews
Here are some of the latest health and medical news developments, compiled by editors of HealthDay:
Fablyn Increases Risk of Blood Clots: FDA Document
While the new osteoporosis drug Fablyn has been shown to be effective in postmenopausal women with...
Here are some of the latest health and medical news developments, compiled by editors of HealthDay:
Senate Bill Would Relax U.S. Ban on Visitors With HIV
An amendment to a global AIDS bill working its way through the U.S. Senate would ease a...
FRIDAY, Sept. 5 -- Plaque ruptures in arteries can occur without causing any symptoms, say researchers at Boston University School of Medicine.
Atherosclerotic plaque often develops at branch points or curving portions of arteries, where blood flow...
FRIDAY, Sept. 5 -- Suppose you're a healthy, physically fit, nonsmoking male. Your risk of heart attack is already low. Would having a drink or two of alcohol a day provide any additional protective benefit?
A study by Harvard University researchers...
FRIDAY, Sept. 5 -- Variations of two new genes appear to increase the risk of developing inflammatory bowel disease in childhood, researchers say.
Inflammatory bowel disease (IBD) is a painful, chronic inflammation of the gastrointestinal tract. It...
Pharma Industry News
ROCKVILLE, Md., Sept. 5, 2008--The U.S. Food and Drug Administration announced today that it has posted on its Web site its first quarterly report that lists certain drugs that are being evaluated for potential safety issues. The drugs have been...
ATLANTA, September 05, 2008 /PRNewswire/ -- EthicAd, a nonprofit organization devoted to improving public health through consumer education, announces the launch of a new FDA Web site created to help the general public better understand...
WASHINGTON, Sept. 2, 2008 - The House Committee on Energy and Commerce today posted on its website a letter sent to the CEOs of Schering-Plough and Merck & Co. over the SEAS study. The letter is...
THOUSAND OAKS, Calif. & COLLEGEVILLE, Pa.--(BUSINESS WIRE)--Sep 4, 2008 - Amgen (NASDAQ: AMGN) and Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), issued a statement in response to the Food and Drug Administration (FDA) safety...
WINSTON-SALEM, N.C., Sept. 5, 2008– Free drug samples provided to physicians by pharmaceutical companies could actually be costing uninsured patients more in the long run, according to a study done by researchers at Wake Forest University...
New Drug Approvals
PRINCETON, New Jersey, September 3, 2008 -- Sandoz has received US Food and Drug Administration approval for its Omnitrope Pen 10 with liquid cartridge. Omnitrope, a somatropin, is approved for long-term treatment of pediatric patients who have...
WOODCLIFF LAKE, N.J., August 23, 2008 /PRNewswire/ -- Eisai Corporation of North America and its partner Helsinn Healthcare SA today announced that the U.S. Food and Drug Administration (FDA) has approved a new oral formulation of Aloxi...
THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Aug 22, 2008 - Amgen Inc. (NASDAQ: AMGN) today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Nplate (romiplostim), the first and only platelet producer for the...
SUMMIT, N.J.--(BUSINESS WIRE)--Aug 21, 2008 - Celgene Corporation today announced Vidaza (azacitidine) received expanded U.S. Food and Drug Administration (FDA) approval to reflect new overall survival achieved in the AZA-001 survival study of...
WASHINGTON, August 15, 2008 /PRNewswire/ -- Prestwick Pharmaceuticals, Inc., a privately-held pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved Xenazine (tetrabenazine) for the treatment of chorea...
New Drug Applications
AUSTIN, Texas--(BUSINESS WIRE)--Sep 2, 2008 - Introgen Therapeutics, Inc., a developer of targeted molecular therapies for cancer, today announced that the United States Food and Drug Administration (FDA) notified the Company that its Biologics...
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Sep 2, 2008 - Alpharma Inc., a global specialty pharmaceutical company, today announced that the United States Food and Drug Administration ("FDA") has advised the Company that its New Drug Application ("NDA") for...
RALEIGH, N.C.--(BUSINESS WIRE)--Aug. 28, 2008 - BioDelivery Sciences International, Inc. (Nasdaq:BDSI) today announced receipt of a Complete Response letter from the U.S. Food and Drug Administration (FDA) regarding the Company's New Drug...
TITUSVILLE, N.J., August 26, 2008 /PRNewswire/ -- Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) announced today that the Food and Drug Administration (FDA) has asked for additional data before it will approve the company's...
VANCOUVER and DEERFIELD, IL, August 11, 2008 /PRNewswire-FirstCall/ - Cardiome Pharma Corp. and its co-development partner Astellas Pharma US, Inc. ("Astellas") today announced that they have received an action letter dated August 8, 2008 from the...
Clinical Trials
M. D. Anderson-led team develops first-ever for African-Americans, expands previous model
HOUSTON, Sept. 5, 2008 – Lung cancer risk prediction models are enhanced by taking into account risk factors by race and by measuring DNA...
NASHVILLE, Tenn.--(BUSINESS WIRE)--Sep 5, 2008 - Sarah Cannon Research Institute (SCRI) investigators have found that "smart bomb" therapies are effective in treating breast cancer patients while minimizing side effects.
Howard A. Burris III, M.D.,...
The study will be presented today in advance of the American Society for Clinical Oncology Breast Cancer Symposium.
Approximately 30 percent of breast cancer cells have an excess amount of the HER2 protein on their surface, which makes the...
BETHESDA, Md., Sept. 4, 2008--The Cancer Genome Atlas (TCGA) Research Network, a collaborative effort funded by the National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI) of the National Institutes of Health (NIH),...
Dr. Jason Slingsby, CEO of ProtAffin commented: “I am encouraged that the FDA has approved the Orphan Drug designation for PA401 for the prevention of delayed graft function after solid organ transplantation. This encouraging...
More News Resources
Daily MedNews
Pharma Industry News
New Drug Applications
New Drug Approvals
Clinical Trial Results
Generic Drug Approvals
